Pre-order Enquiry
Request Free Sample
Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021
SKU ID : TNV-11313771 | Publishing Date : 27-Sep-2017 | No. of pages : 88
About Hematopoietic Stem Cells Transplantation (HSCT)
HSCT is the most widely used stem-cell therapy, where blood from umbilical cord is used. Research is being undertaken to discover various sources (such as cord blood cells, bone marrow, and peripheral blood cells) of hematopoietic stem cells to treat various disorders like hematological malignancies, blood related disorders (leukemia and lymphoma), neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.
Stem-cell therapy has become controversial after developments in isolating and culturing of embryonic stem cells. Somatic cell nuclear transfer is the technique used in embryonic stem cell research to create stem cells and induced pluripotent stem cells. This controversy is related to abortion policies and human cloning. However, the changing regulatory landscape in countries like the US and Japan may help to accelerate the clinical trials.
Technavio’s analysts forecast the global hematopoietic stem cells transplantation (HSCT) market to grow at a CAGR of 5.75% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global hematopoietic stem cells transplantation (HSCT) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of hematopoietic stem cells transplantation (HSCT).
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AllCells
• Lonza
• Merck
• Sanofi
Other prominent vendors
• Athersys
• Beike Biotechnology
• BioTime
• bluebird bio
• Caladrius
• Cellular Biomedicine Group
• Cellular Dynamics International (a subsidiary of Fujifilm)
• Cesca Therapeutics
• CHA Biotech
• CORESTEM
• Gamida Cell
• Global Stem Cells Group
• Hemostemix
• Histocell
• Mesoblast
• TiGenix
• Translational Biosciences (a subsidiary of Medistem Panama)
Market driver
• Rising number of HSCT
• For a full, detailed list, view our report
Market challenge
• High cost of HSCT
• For a full, detailed list, view our report
Market trend
• Growing demand for personalized medicine
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
HSCT is the most widely used stem-cell therapy, where blood from umbilical cord is used. Research is being undertaken to discover various sources (such as cord blood cells, bone marrow, and peripheral blood cells) of hematopoietic stem cells to treat various disorders like hematological malignancies, blood related disorders (leukemia and lymphoma), neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.
Stem-cell therapy has become controversial after developments in isolating and culturing of embryonic stem cells. Somatic cell nuclear transfer is the technique used in embryonic stem cell research to create stem cells and induced pluripotent stem cells. This controversy is related to abortion policies and human cloning. However, the changing regulatory landscape in countries like the US and Japan may help to accelerate the clinical trials.
Technavio’s analysts forecast the global hematopoietic stem cells transplantation (HSCT) market to grow at a CAGR of 5.75% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global hematopoietic stem cells transplantation (HSCT) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of hematopoietic stem cells transplantation (HSCT).
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AllCells
• Lonza
• Merck
• Sanofi
Other prominent vendors
• Athersys
• Beike Biotechnology
• BioTime
• bluebird bio
• Caladrius
• Cellular Biomedicine Group
• Cellular Dynamics International (a subsidiary of Fujifilm)
• Cesca Therapeutics
• CHA Biotech
• CORESTEM
• Gamida Cell
• Global Stem Cells Group
• Hemostemix
• Histocell
• Mesoblast
• TiGenix
• Translational Biosciences (a subsidiary of Medistem Panama)
Market driver
• Rising number of HSCT
• For a full, detailed list, view our report
Market challenge
• High cost of HSCT
• For a full, detailed list, view our report
Market trend
• Growing demand for personalized medicine
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
